Literature DB >> 2882598

Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.

J M Conlon, C F Deacon, G Richter, F Stöckmann, W Creutzfeldt.   

Abstract

Antisera of defined regional specificity have been used to measure the concentration of substance P-like immunoreactivity (SP-LI) and neurokinin A-like immunoreactivity (NKA-LI) during a meal-induced flush in 10 patients with metastatic carcinoid tumours. Although all patients flushed, NKA-LI levels in five patients and SP-LI in six patients were not elevated relative to healthy subjects (NKA-LI, less than 3 pg/ml; SP-LI, less than 10 pg/ml) both in the fasted state and after food. In the patients with elevated basal plasma tachykinin levels, increases in NKA-LI and SP-LI after food were erratic and did not correspond to a defined digestive phase or the occurrence of the flush. Chromatographic analysis of plasma demonstrated the presence of neuropeptide K and neurokinin A, and the detection of COOH-terminal fragments of substance P is consistent with the higher levels of circulating SP-LI measured with a COOH-terminally directed antiserum compared with an NH2-terminally directed antiserum. Subcutaneous injection of the somatostatin analogue SMS 201-995 (50 micrograms) alleviated symptoms of flush in two of three patients but only partially suppressed NKA-LI and SP-LI concentrations. It is concluded that circulating tachykinins cannot be solely responsible for the meal-induced carcinoid flush.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2882598     DOI: 10.3109/00365528708991864

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

Review 1.  Management of carcinoid syndrome.

Authors:  A Saini; J Waxman
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

2.  What is the cause of the carcinoid flush?

Authors:  D G Grahame-Smith
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

3.  Digestibility and bulking effect of ispaghula husks in healthy humans.

Authors:  P Marteau; B Flourié; C Cherbut; J L Corrèze; P Pellier; J Seylaz; J C Rambaud
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

4.  Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.

Authors:  H J Balks; J M Conlon; W Creutzfeldt; F Stöckmann
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Treatment of gastric carcinoids.

Authors:  Wei Hou; Mitchell L Schubert
Journal:  Curr Treat Options Gastroenterol       Date:  2007-04

6.  Calcitonin, as SMS 201-995, ameliorates the VIPoma syndrome.

Authors:  A Antonelli; C Gambuzza; F Bertoni; L Baschieri
Journal:  J Endocrinol Invest       Date:  1993-01       Impact factor: 4.256

7.  Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.

Authors:  G B Turner; B T Johnston; D R McCance; A McGinty; R G P Watson; C C Patterson; J E S Ardill
Journal:  Gut       Date:  2006-03-23       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.